Filing Flows

Filing Flows › Backblaze (BLZE) › Q3 2026 › vs Q2 2026

Backblaze (BLZE) Q3 2026 vs Q2 2026 (quarter over quarter)

Backblaze's revenue rose $3.9M (+9%) from $42.7M in Q2 2026 to $46.7M in Q3 2026. The biggest changes: Consumption-based arrangements +$4.0M (+15%); Subscription-based arrangements −$40K (-0.2%).

Backblaze, Q3 2026: revenue $46.7M (+26% year over year), operating margin -3.0%, net loss $2.4M, operating cash flow $9.0M. The chart draws each line against Q2 2026, the increases inside each band.

Backblaze: what changed, Q3 2026 vs Q2 2026Backblaze: what changed, Q3 2026 vs Q2 2026Consumption-based arrangements$4.0MFree cash flow (OCF − capex)−$3.5MWorking capital & other$3.3MNet loss−$2.7MNet loss absorbed−$2.7MCapital expenditures$2.1MShare-based compensation−$1.5MOperating cash flow−$1.4MCosts & expenses$1.2MOperating costs$1.2M

Margins

Q3 2026Q2 2026Change
Free cash flow margin13.1%22.5%-9.5 pts

Every line

LineQ3 2026Q2 2026Change%
Consumption-based arrangements$29.9M$25.9M$4.0M+15%
Subscription-based arrangements$16.7M$16.7M−$40K-0.2%
Revenue$46.7M$42.7M$3.9M+9%
Net loss$2.4M$5.1M−$2.7M-54%
Costs & expenses$49.0M$47.8M$1.2M+3%
Operating costs$48.1M$46.9M$1.2M+3%
Interest & other, net$894K$875K$19K+2%
Income tax$60K$40K$20K+50%
Cost of revenue$16.8M$15.9M$937K+6%
Research & development$11.3M$11.0M$344K+3%
Sales & marketing$10.7M$10.2M$524K+5%
General & admin$9.2M$9.8M−$628K-6%
Operating cash sources$15.3M$16.2M−$836K-5%
Depreciation & amortization$7.7M$7.0M$657K+9%
Share-based compensation$7.7M$9.2M−$1.5M-16%
Net loss absorbed$2.4M$5.1M−$2.7M-54%
Working capital & other$4.0M$657K$3.3M+504%
Operating cash flow$9.0M$10.4M−$1.4M-14%
Free cash flow (OCF − capex)$6.1M$9.6M−$3.5M-37%
Capital expenditures$2.9M$802K$2.1M+262%

Questions

How much did Backblaze's revenue grow quarter over quarter in Q3 2026?

Backblaze's revenue rose $3.9M (+9%) from $42.7M in Q2 2026 to $46.7M in Q3 2026.

What drove Backblaze's revenue change in Q3 2026?

Consumption-based arrangements +$4.0M (+15%); Subscription-based arrangements −$40K (-0.2%).

Q3 2026 results → · Compare in the interactive Sankey →